1. < Home

secondary hyperparathyroidism

Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Pilot Randomized Clinical Trial

Bishop CW, Ashfaq A, Choe J, Strugnell SA, Johnson LL, Norris KC, Sprague SM. Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism[...]

By afschroeder • February 11, 2026
Adjunctive Active Vitamin D Decreases Kidney Function during Treatment of Secondary Hyperparathyroidism with Extended-Release Calcifediol in Non-Dialysis Chronic Kidney Disease in a Randomized Trial

Ashfaq A, Choe J, Strugnell SA, Patel N, Sprague SM, Norris KC, Lerma E, Petkovich PM, Bishop CW, Ashfaq A. Adjunctive Active Vitamin D Decreases[...]

By afschroeder • August 26, 2025
Comparative effects of calcitriol and calcimimetic on bone health in renal insufficiency

Díaz-Tocados JM, Rodríguez-Ortiz ME, Herencia C, López-Baltanás R, Jurado-Montoya D, García-Saez RM, Valdés-Díaz K, Martínez-Moreno JM, Santamaría R, Pendón-Ruiz de Mier MV, Rodelo-Haad C, Frazão[...]

By sjmartinez • June 8, 2024